Page 30 - ARNM-2-2
P. 30
Advances in Radiotherapy
& Nuclear Medicine Generative AI enhances radiotherapy
long-term viability of CR practices. This integration not eliminate any remaining cancer cells and reduce the risk of
only advances the technical aspects of CR but also reflects recurrence. If used before surgery, it is termed neoadjuvant
3
a commitment to ethical and inclusive practices. The therapy, with the goal of shrinking tumors and facilitating
journey into this transformative intersection promises not more effective surgical removal. 3
only to refine treatment outcomes but also to redefine the CR is used in the treatment of various types of cancer
landscape of CR for the future.
(solid tumors or hematologic malignancies). CR is highly
The primary objectives of this article are to explore and effective in treating a wide range of solid tumors, including
elucidate the multifaceted role of GAI and CS in optimizing but not limited to breast cancer, lung cancer, prostate
CR. The article aims to comprehensively examine cancer, head-and-neck cancer, and gastrointestinal cancer.
2
how advanced artificial intelligence (AI) techniques In addition, radiation therapy is used in the treatment
(particularly generative models) and CS principles can of hematologic malignancies, such as lymphomas and
synergistically contribute to enhancing various facets leukemias. 2
of CR, including treatment planning, adaptation, and There are two primary methods for delivering radiation
resource optimization.
to the cancer site. External beam radiation is administered
By investigating the potential applications and benefits from outside the body by directing high-energy beams
of AI-driven strategies in the context of CR, the article (photons, protons, or particle radiation) to the tumor
seeks to provide insights into the transformative impact location, representing the most common approach in
of these technologies on the precision, efficiency, and the clinical setting. Conversely, internal radiation, or
4
sustainability of radiotherapy treatments. In addition, the brachytherapy, involves the delivery of radiation from
article endeavors to identify potential challenges and ethical inside the body using radioactive sources, which are
considerations, fostering a comprehensive understanding sealed in catheters or seeds directly at the tumor site.
of the integration of AI and CS in the field of CR. Brachytherapy is particularly used in routine treatment as
well as in situations where retreatment is indicated, due to
2. Conceptualization its short-range effects. 5
2.1. CR CR remains a critical and versatile tool in cancer
CR plays a crucial role in cancer treatment and is a treatment, serving as either a primary treatment or
cornerstone of the multidisciplinary approach to managing adjuvant therapy. Its significance is underscored by its
various types of cancers. This therapeutic modality utilizes ability to control or eliminate tumors, contribute to a
1
ionizing radiation to target and destroy cancer cells, with multidisciplinary approach, and improve the overall
the primary objective of either eliminating the tumor or prognosis and quality of life for cancer patients.
controlling its growth. 2
2.2. GAI
CR can be used with the intention of cure, for disease
control, for local tumor control, or in combination with GAI refers to a category of AI systems and models capable
of autonomously generating new, original content. Unlike
other treatments. In cases of curative intent where the traditional AI models, which primarily focus on tasks,
2
cancer is localized, CR aims at completely eradicating such as classification or prediction, generative models are
cancer cells and achieving long-term remission. In
controlling the disease (in metastatic or advanced cases), specifically designed to create novel data, including images,
6
CR can be employed to control tumor growth, relieve text, music, or other forms of content. These developments
symptoms, and prolong survival. As a local tumor control, in AI have enabled new paradigms of machine processing,
CR is often employed as a primary treatment modality shifting from data-driven, discriminative AI tasks toward
sophisticated and creative tasks through GAI.
7
for localized tumors, aiming to eradicate cancer cells
within the target area, preventing further growth and AI encompasses various computational techniques
potential spread to adjacent tissues. It can also be used in capable of undertaking tasks typically associated with
2
combination with other treatments as part of a multimodal human intelligence, such as comprehending natural
approach, combining it with surgery, chemotherapy, and language, identifying patterns, making decisions, and
immunotherapy. This comprehensive approach aims to learning from experience. 8
3
address cancer at different levels and stages. A subset of AI, machine learning, involves the
Combined with surgery, CR can be characterized as development of algorithms that can autonomously handle
adjuvant or neoadjuvant therapy. If used after surgery, it tasks by learning from data without explicit programming.
9
is termed adjuvant therapy; in this case, radiation aims to Within machine learning, different approaches exist,
Volume 2 Issue 2 (2024) 2 doi: 10.36922/arnm.3523

